Skip to content
MARKETS / NASDAQ / OBIO
NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP

Orchestra BioMed Holdings, Inc. OBIO

5 fiscal years on record · USD · FY2025 reported · SEC filings only
$33.5M
▲ 1169.2% YoY
$-52.7M
$-49.5M
Growth
USD 33.5M
Revenue, FY2025 · full 5-year series below
Revenue $M Net income $M
FY2025 · Revenue 33.5 · Net income -52.7
20.0M-25.0M-50.0M20212022202320242025
Compound annual growth
+111.6%
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−157 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -154.7% · Net -157.4%
-1000%-2000%20212022202320242025
ROE

No chart to show — the reason differs by year; see each year in the table below.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -49.5
-20M-40M20212022202320242025

Total assetsUSD 114.9M
CashUSD 34.7M
Gross debtUSD 15.0M
Net debtUSD -19.7M
Current ratio6.45×

Not available: we don't have the shareholders' equity figure for this period.

The 5-year record
5 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20252024202320222021
Revenue $B0.00.00.00.0·
Operating income $B−0.1−0.1−0.1−0.0−0.0
EBITDA $B−0.1−0.1−0.1−0.0·
Income tax $B0.0····
Net income $B−0.1−0.1−0.0−0.0−0.0
Free cash flow $B−0.0−0.1−0.0−0.0·
EPS, diluted $−1.11−1.66−1.48−2.24−0.02
Dividend / sh $·····
Payout %·····
ROE %·····
Shares out B0.060.040.040.020.00

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 20 reconciliationsAUDITED

Reconciled in 5 of 19 fiscal years. 71 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivitySurgical & Medical Instruments & Apparatus
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2021

Share this section

Download image